HIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmission
about
Contrasting Adult and Infant Immune Responses to HIV Infection and VaccinationOptimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based DesignBroadly Neutralizing Antibodies for HIV EradicationNeutralizing Monoclonal Antibodies to Fight HIV-1: On the Threshold of Success.Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo.Antibodies for prevention of mother-to-child transmission of HIV-1Prevention of mother-to-child transmission of HIV type 1: the role of neonatal and infant prophylaxis.History of the prevention of mother-to-child transmission of HIV in Thailand.Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaquesSynergistic Neutralization of Pertussis Toxin by a Bispecific Antibody In Vitro and In VivoPopulation pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults.Behaviorally and perinatally HIV-infected young women: targets for preconception counseling.Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults.Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity.Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials.
P2860
Q26776518-582C0D1F-D73D-49AD-A229-CB70A714EB34Q27644646-DCB6C08A-B143-445E-9DAC-A9DFA4D951E3Q28073939-0F21FDD8-4725-4226-AE7C-40EED7495EDCQ34550046-0E3FBB88-F216-4DDC-9EAF-CF4FC8675A98Q34593860-8D6C0A2F-7258-4E01-B511-42A666569269Q35619402-906E7D80-AF58-4F18-9010-15469A6EF67CQ35751105-0FC39125-D9FB-4057-BF5E-318AA0D65B1EQ37136224-6B088453-B32D-4E52-BC37-630B620F2D93Q37171570-FBA5D904-D133-4863-974F-C59446609F13Q37396968-769BDF9E-F1FC-4FBB-8FD9-A68456F1C74BQ38736222-278FA747-1139-43BF-9CF4-0E2DE59DF2E2Q40572028-6338F5B5-97A9-439C-B71C-CAFFC8C9C016Q41019767-D92EDE76-EF9B-444B-9D0A-4F90441D2869Q42638889-2220334B-CD4E-4780-9A17-A677BA888B34Q44536209-753260B7-16D4-4452-A80A-09285EC4A2CEQ52577900-3E73C871-3E2E-4CBA-A0BF-770D80867048Q54230395-D17CB61D-BAA2-42BE-9C7C-179FC16DB2DF
P2860
HIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmission
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HIV monoclonal antibodies: a n ...... ther-to-child HIV transmission
@ast
HIV monoclonal antibodies: a n ...... ther-to-child HIV transmission
@en
HIV monoclonal antibodies: a n ...... ther-to-child HIV transmission
@nl
type
label
HIV monoclonal antibodies: a n ...... ther-to-child HIV transmission
@ast
HIV monoclonal antibodies: a n ...... ther-to-child HIV transmission
@en
HIV monoclonal antibodies: a n ...... ther-to-child HIV transmission
@nl
prefLabel
HIV monoclonal antibodies: a n ...... ther-to-child HIV transmission
@ast
HIV monoclonal antibodies: a n ...... ther-to-child HIV transmission
@en
HIV monoclonal antibodies: a n ...... ther-to-child HIV transmission
@nl
P2093
P2860
P3181
P1433
P1476
HIV monoclonal antibodies: a n ...... ther-to-child HIV transmission
@en
P2093
Coleen K Cunningham
Elizabeth J McFarland
Jeffrey T Safrit
Lynne M Mofenson
Mary G Fowler
William Snow
Yegor Voronin
P2860
P304
P3181
P356
10.1371/JOURNAL.PMED.1001616
P407
P577
2014-04-01T00:00:00Z